drugset / Trial / NCT02498236

Target Engagement for Oxytocin: Dose Ranging Study

NCT02498236 ↗

RandomizedCrossoverTriple-blindOther

Summary

This study will evaluate the effect of 8 doses of intranasal oxytocin or placebo on two proposed measures of target engagement in brain. The targets are (1) the suppression of a particular wave form (mu) on the electroencephalogram (EEG) while subjects observe a socially relevant form of motion and (2) pupil dilation will subjects identify faces showing different emotions.

Timeline

Start
2015-09
Primary completion
2017-07-01
Completion
2017-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide — Intranasal

Indications